innovative method for quality control of high molecular weight semi synthetic vaccines n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Innovative Method For Quality Control of High Molecular Weight Semi-synthetic Vaccines PowerPoint Presentation
Download Presentation
Innovative Method For Quality Control of High Molecular Weight Semi-synthetic Vaccines

Loading in 2 Seconds...

play fullscreen
1 / 16

Innovative Method For Quality Control of High Molecular Weight Semi-synthetic Vaccines - PowerPoint PPT Presentation


  • 112 Views
  • Uploaded on

Innovative Method For Quality Control of High Molecular Weight Semi-synthetic Vaccines. Dietmar Tietz, Ph.D., PMP DJT Consultants Laurel, Maryland, USA djt@his.com. 2nd World Conference on Magic Bullets (Paul Ehrlich II) Nuremberg 2008. The Vaccine:

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Innovative Method For Quality Control of High Molecular Weight Semi-synthetic Vaccines' - tarik-beck


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
innovative method for quality control of high molecular weight semi synthetic vaccines

Innovative Method For Quality Control of High Molecular Weight Semi-synthetic Vaccines

Dietmar Tietz, Ph.D., PMP

DJT Consultants

Laurel, Maryland, USA

djt@his.com

2nd World Conference on Magic Bullets (Paul Ehrlich II)

Nuremberg 2008

slide2

The Vaccine:

High molecular weight protein-polysaccharide conjugated vaccines prepared to protect infants from infections with bacterial meningitis (Haemophilus influenzae type b, Hib). Samples were kindly donated by Robbins and Schneerson (NICHD, NIH, Bethesda).

    • Bacterial coat polysaccharide particles were obtained by sonication of bacteria. To increase immunogenicity, harvested capsular polysaccharide particles were conjugated with proteins, e.g., toxoided tetanus toxin and Haemophilus protein P2.
    • Covalent attachment of proteins converts the polysaccharide to a T-cell dependent antigen that triggers a protective immune response in small children.
slide3

The Challenge:

  • The effectiveness of earlier vaccine samples was unpredictable. This was likely a result of randomizing steps - sonication & crosslinking - in the preparation of these vaccines.
  • Immunological testing for activity was very time-consuming.
  • Gel filtration was not a useful analytical method, since vaccine particles were so large that they appeared in the void volume.
slide4

EnvisionedMagic BulletSolution:

  • Fast analytical procedure for predicting vaccine effectiveness based on physical parameters of vaccine particles.
  • Strategy:
  • Develop a computer-assisted gel electrophoretic procedure that exploits differences in sample charge and size.
slide5

1-D Gel Electrophoresis

  • We used a horizontal electrophoresis apparatus with buffer-submersed agarose gels (developed by P. Serwer UTHSC, San Antonio, Texas). This apparatus was especially designed for the analysis of very high molecular weight particles such as intact viruses.
  • The image shows gel patterns of non-denatured meningitis vaccines at different agarose concentrations. The samples yielded an uninterpretable smear, although electrophoretic conditions were appropriate based on co-electrophoresis of samples with narrowly defined particle size distributions.
slide6

2-D Gel Patterns

  • (Serwer apparatus with submersed gels)
  • (I-III) Non-denatured vaccine preparations, (S) two carboxylated polystyrene samples used for standardization.

Standardized by overlay of curvilinear size/charge nomogram (Tietz et al.)

slide7

2-D Gel Patterns

Patterns of original images that have been transformed from a curvilinear to a rectangular coordinate system of particle size and mobility, which is related to charge (Tietz et al.).

  • Vaccine I was ineffective.
  • Vaccines II and III are effective immunogens.
  • Vaccine II is a mixture of vaccine batches.
  • Vaccine III is crosslinked with well-defined protein P2.
slide8

Vaccine II:Progressive stripping of vaccine particle surfaces indicates the presence of three major subpopulations (Tietz et al.).

magic bullet solution and biomedical significance
Magic BulletSolution and Biomedical Significance

Vaccine quality control based on physical parameters

  • Results available within a day or two, not months!
  • Characteristic 2-D patterns for each conjugate preparation
  • Useful for determining vaccine effectiveness and the impact of storage, lyophilization, and sterile filtration
  • Applicable for any high-molecular weight vaccine

and particles as large as or larger than intact viruses

comparison of technologies and costs then and now
1983 - 1995:

Precision Perkin Elmer microdensitometer ($300k) interfaced with two mainframe computers ($300k)

Trained computer operators required

Custom-made electrophoresis equipment with bulky cooling systems, pumps, and power supplies (~$30K)

Today:

Digital camera interfaced with desktop or laptop computer ($2k)

Do-it-yourself option

Nifty, small-footprint electrophoresis equipment with Peltier cooling (~$2k - $5k)

Comparison of Technologies and Costs Then and Now

Modern technology makes this innovative 2-D method affordable and much more practical.

slide11

Innovative Method For Quality Control of High Molecular Weight Semi-synthetic Vaccines

Dietmar Tietz, Ph.D., PMP

DJT Consultants, Laurel, Maryland, USA  Email: djt@his.com

Three more slides available for the discussion of methods!

2nd World Conference on Magic Bullets (Paul Ehrlich II)

Nuremberg 2008

2 d serwer type gels vs 2 d o farrell gels
Serwer-type - used for vaccines

Lower (1st) and higher (2nd) concentration submersed agarose gels used to achieve predominant separation according to charge or size in one direction.

Non-denaturing conditions

Gels not touched

Used for subcellular-sized particles with a size of 2,000 kD - 2,000,000+ kD (size of intact viruses and larger).

O'Farrell-type - for comparison

Isoelectric focusing and SDS polyacrylamide gel electrophoresis (sieving) used to achieve 2-D separation according to charge and size.

Denaturing conditions

Transfer of gel slab

Used for macromolecules with a typical size range of 20 kD - 500 kD.

2-D Serwer-type Gels vs. 2-D O’ Farrell Gels

slide14

Schematic of the

horizontal bidirectional electrophoresis apparatus with buffer-submersed agarose gels (Philip Serwer)

slide15

Iso-size and iso-free-mobility nomogram for the evaluation of two-dimensional gel patterns

(Tietz et al.)

slide16

References

  • Robbins, JB, Schneerson, R, Anderson, P, Smith, DH, JAMA 1996, 276, 1181–1185.
  • Tietz, D, Aldroubi, A, Schneerson, R, Unser, M, Chrambach, A, Electrophoresis 1991, 12, 46-54.
  • Tietz, D, Electrophoresis 2007, 28, 512–524.
  • Serwer, P, Anal. Biochem. 1985, 144, 172-178.